2:43 am Alexion Pharma: NICE confirms AGNSS Positive assessment that Eculizumab is a very effective treatment for aHUS patients and produces substantial quality-adjusted life year gains of a magnitude rarely seen for a new drug
View todays social media effects on ALXN
View the latest stocks trending across Twitter. Click to view dashboard
See who Alexion is hiring next, click here to view
